Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype

Published:2021-02 Issue:6 Volume:56 Page:1496-1503
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

McGarry Meghan E.¹^ORCID,McColley Susanna A.²³^ORCID

Affiliation:

1. Department of Pediatrics University of California San Francisco California USA

2. Department of Pediatrics Northwestern University Feinberg School of Medicine Chicago Illinois USA

3. Department of Pediatrics, Stanley Manne Children's Research Institute Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois USA

Funder

Cystic Fibrosis Foundation Therapeutics

National Heart, Lung, and Blood Institute

Cystic Fibrosis Foundation

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.25285

Reference42 articles.

1. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation

2. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

3. Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

4. Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

5. Lumacaftor/Ivacaftor in Patients Aged 6–11 Years with Cystic Fibrosis and Homozygous forF508del-CFTR

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Further therapeutic applications of mRNA and saRNA;mRNA Therapeutics;2025

2. Assessment of patients' baseline cystic fibrosis knowledge levels following translation and adaptation of the CF R.I.S.E translation program into Turkish;Pediatric Pulmonology;2024-09-02

3. Advances in Care and Outcomes for Children with Cystic Fibrosis;Clinics in Chest Medicine;2024-09

4. Functional and radiological sinonasal outcomes of CFTR modulators for sinus disease in cystic fibrosis: A meta‐analysis;International Forum of Allergy & Rhinology;2024-08-30

5. The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulators;Expert Review of Respiratory Medicine;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3